过去一年中添加的文章,按日期排序

… in Biology, Classification, and Management of Acute Myeloid Leukemia with Antecedent Hematologic Disorder and Therapy Related Acute Myeloid Leukemia

K Parmar, R Kundu, A Maiti, S Ball - Leukemia Research, 2024 - Elsevier
10 天前 - … -risk cytogenetic and molecular alterations associated with AHD or prior cancer
therapy. … In this review, we summarize the epidemiology, genetic characteristics, outcomes with …

[HTML][HTML] Genomic landscape of CCUS compared to MDS and its implications on risk prediction

S Huber, C Baer, S Hutter, N Wossidlo, G Hoermann… - Leukemia, 2024 - nature.com
60 天前 - … and cytogenetic aberrations [3], while more recently cytogenetic and molecular
genetic data are integrated with clinical parameters into the Molecular International Prognostic …

Advances in decision support for diagnosis and early management of acute leukaemia

AT Turki, M Engelke, M Sobas - The Lancet Digital Health, 2024 - thelancet.com
76 天前 - … practice; genetic examinations (eg, cytogenetic and molecular-genetics examinations
… FLT3 and NPM1 mutations in acute myeloid leukemia. Ann Hematol 2013; 92: 451–57. …

Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management

N Szuber, A Orazi, A Tefferi - American Journal of Hematology, 2024 - Wiley Online Library
80 天前 - … lineage, presence of an acquired clonal cytogenetic or molecular abnormality (both …
for MDS and presence of clonality by abnormal cytogenetics or presence of mutations, the …

Influence of genetic polymorphisms on imatinib concentration and therapeutic response in patients with chronic-phase chronic myeloid leukemia

F Cheng, Z Cui, Q Li, S Chen, W Li, Y Zhang - International …, 2024 - Elsevier
83 天前 - … We examined the impact of genetic polymorphisms of imatinib … in 190 patients with
chronic myeloid leukaemia (CML). … of cytogenetic and molecular response in chronic myeloid

[HTML][HTML] Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations

N Curik, A Laznicka, V Polivkova, J Krizkova… - Leukemia, 2024 - nature.com
87 天前 - Despite significant progress in chronic myeloid leukemia (CML) therapy over recent
decades, the blast crisis (BC) remains a therapeutic challenge. This advanced disease …

[HTML][HTML] Cytogenetics and genomics in CML and other myeloproliferative neoplasms

HH Kreipe, B Schlegelberger - Best Practice & Research Clinical …, 2024 - Elsevier
97 天前 - Chronic myeloid leukemia is defined by the presence of the Philadelphia translocation
t (9; 22) resulting in the BCR::ABL1 fusion. The other myeloproliferative neoplasms (MPN…

Clinicopathologic and molecular genetic features of STAT3-mutated myeloid neoplasms

MT Ye, Z Zuo, S Calin, F Ye, H He, W Kamata, MJ You - Cancer Research, 2024 - AACR
109 天前 - molecular genetic features of 32 STAT3-mutated myeloid neoplasms. Twenty (62.5%)
cases were classified as acute myeloid leukemia (… most common cytogenetic abnormality, …

[HTML][HTML] Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy

Y Liu, Y Tu, J Xiao, Y Shen, B Zhou, Q Yang, L Yu… - Blood Cancer …, 2024 - nature.com
126 天前 - Chronic myeloid leukemia (CML) is a triphasic myeloproliferative disorder that
accounts for 15–20% of adult leukemias [1]. The cytogenetic … ::ABL1 fusion gene. Lymphoid blast …

[HTML][HTML] Commentary: Case report: Chronic neutrophilic leukemia associated with monoclonal gammopathies. A case series and review of genetic characteristics and …

Y Deng, S Han, X Gao, Y Liu, J Gao - Frontiers in Oncology, 2024 - frontiersin.org
149 天前 - … the criteria specify persistentmyeloid cells by cytogenetic or molecular studies. In
the report of Vermeersch et al., no evidence of myeloid clones was detected using cytogenetic